J Gerontol:喝咖啡能抑制痴呆症?

2016-10-09 佚名 生物谷

图片来源:medicalxpress.com 近日,一项刊登于国际杂志The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences上的研究报告中,来自威斯康星大学密尔沃基分校的研究人员通过研究揭示了咖啡因和痴呆症预防之间的关联,研究者发现,65岁及以上女性咖啡因的高水平摄入或和机体患痴呆症或认知

图片来源:medicalxpress.com

近日,一项刊登于国际杂志The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences上的研究报告中,来自威斯康星大学密尔沃基分校的研究人员通过研究揭示了咖啡因和痴呆症预防之间的关联,研究者发现,65岁及以上女性咖啡因的高水平摄入或和机体患痴呆症或认知损伤的可能性降低直接相关。

这项研究中包含了6467名女性个体,研究者对个体进行了10多年的追踪研究发现,咖啡因摄入高于261毫克的个体患痴呆症的风险能够降低36%,这种水平等同于每天摄入2-3杯咖啡的量(8盎司/杯)、5-6杯黑茶的量(8盎司/杯)或7-8罐可乐的量((8盎司/罐)。研究者Ira Driscoll教授说道,虽然我们并不能直接阐明较高水平的咖啡因摄入和认知损伤及痴呆症发生率降低直接的关系,但通过后期深入的研究我们或许就能够更好地阐明咖啡因摄入对机体认知健康的重要性;同时本文研究不仅是站在预防的角度上来研究,而且还能够帮助人们更好地理解痴呆症和认知损伤发生的分子机制。

研究者们都知道,咖啡因能够结合大脑中预先的腺苷受体,因此这项研究重点阐明了一种潜在的机制来帮助我们深入探究咖啡因和认知损伤之间的因果关系,越来越多的证据表明,咖啡因的摄入能够作为一种潜在地抵御认知损伤的保护性因子,这或许也就说明咖啡因同时也是一种容易修饰的膳食因子。这项研究中,研究者随着时间对摄入不同量咖啡的女性群体进行研究,检测了其咖啡因摄入和痴呆症发生风险之间的关联。

研究人员利用6467名年龄在65岁及以上绝经女性的研究数据,他们利用调查问卷的形式来评估参与者咖啡因的摄入水平,调查问卷内容包括:咖啡、茶以及可乐饮料的摄入,包括频率及摄入量等。在10年或不到10年的年度认知评估功能测试中,这些参与者中有388名个体接受了可能性痴呆症的诊断或者某种形式的认知损伤检测。研究者希望后期通过更为深入的研究来探究咖啡的摄入和痴呆症之间的具体关联及相关的机制。

原始出处

Ira Driscoll1, Sally A. Shumaker2, Beverly M. Snively3, Karen L. Margolis4, JoAnn E. Manson5, Mara Z. Vitolins6, Rebecca C. Rossom4 and Mark A. Espeland3.Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women’s Health Initiative Memory Study.J Gerontol.2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1836126, encodeId=cda21836126a9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Mar 03 11:59:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021539, encodeId=5e662021539bf, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Aug 25 11:59:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143770, encodeId=56cf143e70ec, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:33 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143769, encodeId=e098143e696b, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:25 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143464, encodeId=73331434649f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:51 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143463, encodeId=ef741434633e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:45 CST 2016, time=2016-10-10, status=1, ipAttribution=)]
    2017-03-03 Boyinsh
  2. [GetPortalCommentsPageByObjectIdResponse(id=1836126, encodeId=cda21836126a9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Mar 03 11:59:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021539, encodeId=5e662021539bf, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Aug 25 11:59:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143770, encodeId=56cf143e70ec, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:33 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143769, encodeId=e098143e696b, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:25 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143464, encodeId=73331434649f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:51 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143463, encodeId=ef741434633e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:45 CST 2016, time=2016-10-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1836126, encodeId=cda21836126a9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Mar 03 11:59:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021539, encodeId=5e662021539bf, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Aug 25 11:59:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143770, encodeId=56cf143e70ec, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:33 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143769, encodeId=e098143e696b, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:25 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143464, encodeId=73331434649f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:51 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143463, encodeId=ef741434633e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:45 CST 2016, time=2016-10-10, status=1, ipAttribution=)]
    2016-10-10 1e0d99ddm02(暂无匿称)

    总结的很好!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1836126, encodeId=cda21836126a9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Mar 03 11:59:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021539, encodeId=5e662021539bf, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Aug 25 11:59:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143770, encodeId=56cf143e70ec, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:33 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143769, encodeId=e098143e696b, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:25 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143464, encodeId=73331434649f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:51 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143463, encodeId=ef741434633e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:45 CST 2016, time=2016-10-10, status=1, ipAttribution=)]
    2016-10-10 1e0d99ddm02(暂无匿称)

    分享一下!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1836126, encodeId=cda21836126a9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Mar 03 11:59:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021539, encodeId=5e662021539bf, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Aug 25 11:59:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143770, encodeId=56cf143e70ec, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:33 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143769, encodeId=e098143e696b, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:25 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143464, encodeId=73331434649f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:51 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143463, encodeId=ef741434633e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:45 CST 2016, time=2016-10-10, status=1, ipAttribution=)]
    2016-10-10 知难而进

    继续关注!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1836126, encodeId=cda21836126a9, content=<a href='/topic/show?id=4613e1212fc' target=_blank style='color:#2F92EE;'>#痴呆症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71212, encryptionId=4613e1212fc, topicName=痴呆症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Mar 03 11:59:00 CST 2017, time=2017-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2021539, encodeId=5e662021539bf, content=<a href='/topic/show?id=31e8e9669d' target=_blank style='color:#2F92EE;'>#GER#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7966, encryptionId=31e8e9669d, topicName=GER)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48732500158, createdName=12498c32m68暂无昵称, createdTime=Fri Aug 25 11:59:00 CST 2017, time=2017-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143770, encodeId=56cf143e70ec, content=总结的很好!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:33 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143769, encodeId=e098143e696b, content=分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160817/IMG57B3C3F6DC2FD8753.jpg, createdBy=81321934679, createdName=1e0d99ddm02(暂无匿称), createdTime=Mon Oct 10 22:02:25 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143464, encodeId=73331434649f, content=继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:51 CST 2016, time=2016-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=143463, encodeId=ef741434633e, content=谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160811/IMG57AC91915ACA64463.jpg, createdBy=9c351934462, createdName=知难而进, createdTime=Mon Oct 10 19:19:45 CST 2016, time=2016-10-10, status=1, ipAttribution=)]
    2016-10-10 知难而进

    谢谢分享!

    0

相关资讯

警惕!咖啡不能和这些药同服!严重会引起中毒

如今,工作时来上一两杯咖啡,即提神又怡情,已成了不少人的日常状态。虽然喝咖啡对身体有益,但咖啡因可能会与一些日常药物产生作用,服药时需要注意与药物的相互作用。以下为不能和咖啡同服的药物!1 安眠药如舒乐安定、地西泮、阿普唑仑等。安眠药是作用于人体神经中枢的镇静催眠药,而咖啡因能引起神经中枢的兴奋,两者作用完全相反。因此在服用上述药品的同时最好不要喝咖啡。2 甲状腺激素药如优甲乐、甲状腺素钠等。根据

Am J Med:喝茶可延缓冠状动脉钙化、降低心血管事件风险

虽然咖啡和茶是世界上最常用的两种饮料,但是,咖啡和茶的摄入量与冠状动脉钙化、主要不良心血管事件之间的关联仍然不明确。 本研究纳入了6508名参与者(来自不同种族),均来自粥样硬化多种族研究(MESA)。研究者获取了参与者咖啡和茶摄入量相关数据,摄入量分为:从不、偶尔(<1杯/天)、定期(≥1杯/天)。 对冠状动脉钙化的中位随访时间超过5.3年,对心血管事件的中位随访时间为11.1年。

咖啡是天使,还是魔鬼?

在睡眼惺忪的早晨,或是慵懒小困的午后,很多人会选择来一杯咖啡提提神。每当路过街角的咖啡店,也常常会被咖啡那难以抗拒的醇厚香气引诱进去。据了解,美国2015年一年内在咖啡上面的消费达到了742亿美元,咖啡在美国的广泛性甚至高于自来水。2014年,全球范围内售出的60千克包装咖啡超过1.5亿份。咖啡已经是当之无愧的大众饮品。 有人喝了咖啡之后神清气爽,精力充沛,思想集中,感觉还能再工作五百年

尽情的享受你的咖啡吧

近日据牙科专家说,咖啡可能会污染牙齿,导致牙齿产生一些污渍,但咖啡对身体健康的好处远大于咖啡对牙齿产生的不良反应。 根据美国牙科学院的研究表明,咖啡可能有助于保护人体肝脏,减少人们患癌症,心脏病和糖尿病等病的风险,帮助体内促进新陈代谢,并使你的大脑时刻保持敏捷的思维。 研究人员相关的早期证据表明,咖啡有助于保护牙齿并防止骨质流失到下颌中。美国牙科学院在美国和加拿大有很多研究成员。 研究人员N

盘点:咖啡与癌症到底有何关联?科学家来解释

睡眼惺忪的清晨或是紧张忙碌的工作中,你是否会来一杯香浓醇厚的咖啡提提神呢? 咖啡是一种将咖啡豆烘培制作出来的含咖啡因的饮料,现今社会,咖啡与可乐,茶同基本已经成为很多人生活中的必需品。近些年来,科学家们进行了很多研究来揭示咖啡和人类机体疾病的关联,其中不乏有研究者将咖啡与癌症之间的关联作为重点的研究项目进行探索, 上周三,世界卫生组织WHO就宣布,饮用较烫的咖啡很可能致癌,

PLoS One:摄入过多的咖啡或可促进牙周炎的发生

本研究旨在使用全国代表性的数据来评估咖啡的摄入与牙周炎发生之间的关系。本研究来源于韩国国家健康和营养检查调查,所纳入的研究对象要求年龄大于19岁,咖啡的消费没有漏失值且结果变量没有漏失值,最后共纳入16730名研究对象。社区牙周指数大于或等于3则被定义为牙周病。结果发现,男性牙周炎患者的咖啡消费量明显较高。牙周炎患者的百分比的比值比似乎随着咖啡的摄入增加而上升。男性参与者每月饮用咖啡≤1次,1次/